Literature DB >> 17786934

NHERFs, NEP, MAGUKs, and more: interactions that regulate PTEN.

Challice L Bonifant1, Jung-Sik Kim, Todd Waldman.   

Abstract

This year marks the 10th anniversary of the discovery of the PTEN/MMAC1/TEP1 tumor suppressor gene (hereafter referred to as PTEN), one of the most commonly mutated genes in cancer. PTEN encodes a lipid phosphatase that dephosphorylates phosphoinositide-3,4,5-triphosphate (PIP(3)), thereby counteracting mitogenic signaling pathways driven by phosphoinositol-3-kinases (PI3K). By opposing PI3K signaling, PTEN inhibits the activation of the critical PI3K effector proteins Akt1-3 (also known as protein kinase B or PKB). Given its central role in antagonizing PI3K signaling, one might expect that like PI3K, the activity of the PTEN protein would be highly regulated by numerous protein/protein interactions. However, surprisingly little is known about such interactions. This fact, combined with the generally accepted notion that phosphatases are less exquisitely regulated than kinases, has led to the idea that PTEN may function in a relatively unregulated fashion. Here we review the identities and proposed functions of known PTEN-interacting proteins, and point out avenues of investigation that we hope may be fruitful in identifying important new mechanisms of PTEN regulation in mammalian cells.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17786934      PMCID: PMC4384183          DOI: 10.1002/jcb.21518

Source DB:  PubMed          Journal:  J Cell Biochem        ISSN: 0730-2312            Impact factor:   4.429


  38 in total

1.  Dual neuroprotective signaling mediated by downregulating two distinct phosphatase activities of PTEN.

Authors:  Ke Ning; Lin Pei; Mingxia Liao; Baosong Liu; Yunzhou Zhang; Wen Jiang; John G Mielke; Lei Li; Yonghong Chen; Youssef H El-Hayek; Michael G Fehlings; Xia Zhang; Fang Liu; James Eubanks; Qi Wan
Journal:  J Neurosci       Date:  2004-04-21       Impact factor: 6.167

2.  Mechanistic insights into maintenance of high p53 acetylation by PTEN.

Authors:  Andrew G Li; Landon G Piluso; Xin Cai; Gang Wei; William R Sellers; Xuan Liu
Journal:  Mol Cell       Date:  2006-08       Impact factor: 17.970

3.  Analysis of phosphatase and tensin homolog tumor suppressor interacting proteins by in vitro and in silico proteomics.

Authors:  David K Crockett; G Chris Fillmore; Kojo S J Elenitoba-Johnson; Megan S Lim
Journal:  Proteomics       Date:  2005-04       Impact factor: 3.984

4.  Threonine phosphorylation of the MMAC1/PTEN PDZ binding domain both inhibits and stimulates PDZ binding.

Authors:  N B Adey; L Huang; P A Ormonde; M L Baumgard; R Pero; D V Byreddy; S V Tavtigian; P L Bartel
Journal:  Cancer Res       Date:  2000-01-01       Impact factor: 12.701

5.  PTEN tumor suppressor regulates p53 protein levels and activity through phosphatase-dependent and -independent mechanisms.

Authors:  Daniel J Freeman; Andrew G Li; Gang Wei; Heng-Hong Li; Nathalie Kertesz; Ralf Lesche; Andrew D Whale; Hilda Martinez-Diaz; Nora Rozengurt; Robert D Cardiff; Xuan Liu; Hong Wu
Journal:  Cancer Cell       Date:  2003-02       Impact factor: 31.743

6.  Identification of a candidate tumour suppressor gene, MMAC1, at chromosome 10q23.3 that is mutated in multiple advanced cancers.

Authors:  P A Steck; M A Pershouse; S A Jasser; W K Yung; H Lin; A H Ligon; L A Langford; M L Baumgard; T Hattier; T Davis; C Frye; R Hu; B Swedlund; D H Teng; S V Tavtigian
Journal:  Nat Genet       Date:  1997-04       Impact factor: 38.330

7.  Thioredoxin-1 binds to the C2 domain of PTEN inhibiting PTEN's lipid phosphatase activity and membrane binding: a mechanism for the functional loss of PTEN's tumor suppressor activity.

Authors:  Emmanuelle J Meuillet; Daruka Mahadevan; Margareta Berggren; Amy Coon; Garth Powis
Journal:  Arch Biochem Biophys       Date:  2004-09-15       Impact factor: 4.013

8.  Regulation of PTEN phosphorylation and stability by a tumor suppressor candidate protein.

Authors:  Fumiaki Okahara; Hideki Ikawa; Yasunori Kanaho; Tomohiko Maehama
Journal:  J Biol Chem       Date:  2004-09-07       Impact factor: 5.157

9.  NHERF (Na+/H+ exchanger regulatory factor) gene mutations in human breast cancer.

Authors:  Jia Le Dai; Lei Wang; Aysegul A Sahin; Lyle D Broemeling; Mieke Schutte; Yong Pan
Journal:  Oncogene       Date:  2004-11-11       Impact factor: 9.867

10.  Synergy in tumor suppression by direct interaction of neutral endopeptidase with PTEN.

Authors:  Makoto Sumitomo; Akira Iwase; Rong Zheng; Daniel Navarro; David Kaminetzky; Ruoqian Shen; Maria-Magdalena Georgescu; David M Nanus
Journal:  Cancer Cell       Date:  2004-01       Impact factor: 31.743

View more
  11 in total

1.  PTEN is recruited to the postsynaptic terminal for NMDA receptor-dependent long-term depression.

Authors:  Sandra Jurado; Marion Benoist; Argentina Lario; Shira Knafo; Cortney N Petrok; José A Esteban
Journal:  EMBO J       Date:  2010-07-13       Impact factor: 11.598

2.  Mechanistic analysis of a DNA damage-induced, PTEN-dependent size checkpoint in human cells.

Authors:  Jung-Sik Kim; Xuehua Xu; Huifang Li; David Solomon; William S Lane; Tian Jin; Todd Waldman
Journal:  Mol Cell Biol       Date:  2011-05-02       Impact factor: 4.272

3.  Pten regulates spindle pole movement through Dlg1-mediated recruitment of Eg5 to centrosomes.

Authors:  Janine H van Ree; Hyun-Ja Nam; Karthik B Jeganathan; Arun Kanakkanthara; Jan M van Deursen
Journal:  Nat Cell Biol       Date:  2016-05-30       Impact factor: 28.824

4.  Neuropeptide Levels as well as Neprilysin Activity Decrease in Renal Cell Carcinoma.

Authors:  Nuray Erin; Tümay İpekçi; Bahar Akkaya; İrem Hicran Özbudak; Mehmet Baykara
Journal:  Cancer Microenviron       Date:  2016-10-19

5.  Expression and activity profiles of DPP IV/CD26 and NEP/CD10 glycoproteins in the human renal cancer are tumor-type dependent.

Authors:  Adolfo Varona; Lorena Blanco; Itxaro Perez; Javier Gil; Jon Irazusta; José I López; M Luz Candenas; Francisco M Pinto; Gorka Larrinaga
Journal:  BMC Cancer       Date:  2010-05-11       Impact factor: 4.430

Review 6.  PTEN and the PI3-kinase pathway in cancer.

Authors:  Nader Chalhoub; Suzanne J Baker
Journal:  Annu Rev Pathol       Date:  2009       Impact factor: 23.472

7.  SLC6A20 transporter: a novel regulator of brain glycine homeostasis and NMDAR function.

Authors:  Mihyun Bae; Junyeop Daniel Roh; Youjoung Kim; Seong Soon Kim; Hye Min Han; Esther Yang; Hyojin Kang; Suho Lee; Jin Yong Kim; Ryeonghwa Kang; Hwajin Jung; Taesun Yoo; Hyosang Kim; Doyoun Kim; Heejeong Oh; Sungwook Han; Dayeon Kim; Jinju Han; Yong Chul Bae; Hyun Kim; Sunjoo Ahn; Andrew M Chan; Daeyoup Lee; Jin Woo Kim; Eunjoon Kim
Journal:  EMBO Mol Med       Date:  2021-01-11       Impact factor: 12.137

8.  Protein kinases and phosphatases in the control of cell fate.

Authors:  Angela Bononi; Chiara Agnoletto; Elena De Marchi; Saverio Marchi; Simone Patergnani; Massimo Bonora; Carlotta Giorgi; Sonia Missiroli; Federica Poletti; Alessandro Rimessi; Paolo Pinton
Journal:  Enzyme Res       Date:  2011-09-04

9.  Functional analysis of the protein phosphatase activity of PTEN.

Authors:  Xiaoqun Catherine Zhang; Antonella Piccini; Michael P Myers; Linda Van Aelst; Nicholas K Tonks
Journal:  Biochem J       Date:  2012-06-15       Impact factor: 3.857

10.  MEK1 is required for PTEN membrane recruitment, AKT regulation, and the maintenance of peripheral tolerance.

Authors:  Katarina Zmajkovicova; Veronika Jesenberger; Federica Catalanotti; Christian Baumgartner; Gloria Reyes; Manuela Baccarini
Journal:  Mol Cell       Date:  2013-02-28       Impact factor: 17.970

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.